Trials / Completed
CompletedNCT04645888
Articaine and Bupivacaine in Impacted Tooth Surgery
Evaluation of the Effects of Articaine and Bupivacaine in Impacted Third Molar Tooth Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Kocaeli University · Academic / Other
- Sex
- All
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
Articaine is a common local anesthetic used in oral surgery and belongs to the amide group of it has fast onset with little side effects. Bupivacaine is preferred in prolonged surgical procedures with its long duration of action and residual analgesic effect. The aim of this study was to evaluate the anesthetic, analgesic, hemodynamic effects of 4% articaine and 0.5% bupivacaine in extraction of impacted mandibular third molar teeth in intraoperative and postoperative periods. Hemodynamic parameters, onset of anesthetic action, total amount, intraoperative comfort, intraoperative bleeding, duration of postoperative anesthesia and analgesia, rescue analgesic use, maximum incisal opening and postoperative pain at 6th, 12th, 24th, 48th and 72th hours and 7th day using a visual analogue scale be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Impacted tooth surgery | Surgical extraction of İmpacted tooth |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2019-02-25
- Completion
- 2019-02-25
- First posted
- 2020-11-27
- Last updated
- 2020-11-27
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04645888. Inclusion in this directory is not an endorsement.